Please wait while the formulary information is being retrieved.
PREPARATION H (HYDROCORTISONE)
- Hemorrhoids
- Pruritus of skin
- Skin inflammation
- Allergic dermatitis
- Atopic dermatitis
- Contact dermatitis
- Cutaneous t-cell lymphoma
- Discoid lupus erythematosus
- Genital organ pruritus
- Granuloma annulare
- Lichen simplex chronicus
- Plaque psoriasis
- Proctitis
- Pruritus ani
- Rectal pain
- Scalp psoriasis
- Seborrheic dermatitis
- Tucks (witch Hazel) Topical Pads
- Soothing Care (hydrocortisone) Topical Cream
- Proctocort Topical Cream
- Preparation H(phenylephrine,cocoa Butter) Rectal Suppository
- Preparation H Topical Gel
- Preparation H Ointment
- Preparation H Maximum Strength Rectal Cream
- Preparation H Hydrocortisone Topical Cream
- Preparation H (witch Hazel) Topical Pads
- Preparation H (phenylephrine,witch Hazel) Topical Gel
- Noble Formula Hc Topical Cream
- Medi-pads Topical Pads
- Major-prep Hemorrhoidal Ointment
- Hydrocream Topical
- Hemorrhoidal Topical Pads
- Hemorrhoidal Hygiene Topical Pads
- Hemorrhoidal Cream Rectal
- Hemorrhoidal Cooling Topical Gel
- Hemorrhoidal (witch Hazel) Topical Pads
- Hemorrhoidal (phenyleph-mineral Oil-petrolatum) Rectal Oint
- Hemorrhoidal (phenyleph-cocoa) Rectal Suppository
- Eczema Anti-itch Topical Cream
- Cortizone-10 Topical Cream
- Cortizone-10 Plus Topical Cream
- Cortisone Topical Cream
- Cortisone (hydrocortisone) Topical Cream
- Cortaid Topical Cream
- Anti-itch (hydrocortisone) Topical Cream
- Ala-cort Topical Cream
- By Indication
(witch hazel) 50 % topical pads
- Dosage information is not available
(hydrocortisone) 1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
(phenyleph,cocoa buttr) 0.25 %-88.44 % rectal suppository
- Dosage information is not available
(phenylephrine,witch hazel) 0.25 %-50 % topical gel
- Dosage information is not available
0.25 %-14 %-74.9 % ointment
- Dosage information is not available
Maximum Strength 0.25 %-1 % rectal cream
- Dosage information is not available
Hydrocortisone 1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Preparation H (Witch Hazel) 20 % topical pads
- Dosage information is not available
Preparation H (Witch Hazel) 50 % topical pads
- Dosage information is not available
(phenylephrine,witch hazel) 0.25 %-50 % topical gel
- Dosage information is not available
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
50 % topical pads
- Dosage information is not available
0.25 %-14 %-74.9 % ointment
- Dosage information is not available
1 % topical
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Hemorrhoidal (witch hazel) 50 % topical pads
- Dosage information is not available
50 % topical pads
- Dosage information is not available
0.25 %-1 % rectal
- Dosage information is not available
Hemorrhoidal Cooling 0.25 %-50 % topical gel
- Dosage information is not available
50 % topical pads
- Dosage information is not available
Hemorrhoidal (witch hazel) 50 % topical pads
- Dosage information is not available
Hemorrhoidal(phenyleph-min oil-petrolat)0.25 %-14 %-74.9 % rectal oint
- Dosage information is not available
0.25 %-88.44 % rectal suppository
- Dosage information is not available
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
(hydro) 1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
(hydro) 1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
(hydrocortisone) 1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Contact dermatitis
- Apply a thin layer to the affected area(s) by topical route once daily
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 3 times per day
- Apply a thin layer to the affected area(s) by topical route 4 times per day
Seborrheic dermatitis
- Apply a thin layer to the affected area(s) by topical route once daily
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 3 times per day
- Apply a thin layer to the affected area(s) by topical route 4 times per day
Skin inflammation
- Apply a thin layer to the affected area(s) by topical route once daily
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 3 times per day
- Apply a thin layer to the affected area(s) by topical route 4 times per day
- isocarboxazid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- tranylcypromine
Contraindicated
- Azilect
- Eldepryl
- linezolid
- rasagiline
- selegiline HCl
- Zelapar
- Zyvox
Severe
Moderate
- methyldopa
- methyldopa-hydrochlorothiazide
- methyldopate
- reserpine
- None
Contraindicated
- Large open wound
Severe
Moderate
- Benign prostatic hyperplasia
- Cardiac arrhythmia
- Coronary artery disease
- Hypertension
- Hyperthyroidism
- Hypothalamic-pituitary insufficiency
- Nervousness
PREPARATION H (HYDROCORTISONE)
- Hemorrhoids
- Pruritus of skin
- Skin inflammation
- Allergic dermatitis
- Atopic dermatitis
- Contact dermatitis
- Cutaneous t-cell lymphoma
- Discoid lupus erythematosus
- Genital organ pruritus
- Granuloma annulare
- Lichen simplex chronicus
- Plaque psoriasis
- Proctitis
- Pruritus ani
- Rectal pain
- Scalp psoriasis
- Seborrheic dermatitis
- None
- Erythema
- Stinging of skin
More Frequent
Severe
Less Severe
- Angioedema
- Dermatitis due to topical drug
- Erythema
- Folliculitis
- Pruritus of skin
- Purpura
- Skin and skin structure infection
- Skin atrophy
- Skin rash
- Stinging of skin
- Urticaria
- Contact dermatitis
- Headache disorder
- Paresthesia
- Pruritus of skin
- Skin rash
- Telangiectasia
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute respiratory insufficiency
- Adrenal cortical insufficiency
- Anaphylaxis
- Bradycardia
- Bullous dermatitis
- Cardiac arrhythmia
- Cataracts
- Central serous chorioretinopathy
- CNS toxicity
- Cyanosis
- Dizziness
- Drowsy
- Eyelid edema
- Glaucoma
- Headache disorder
- Hyperhidrosis
- Hypotension
- Hypothalamic-pituitary insufficiency
- Insomnia
- Methemoglobinemia
- Nervousness
- Ocular hypertension
- Pallor
- Respiratory depression
- Seizure disorder
- Skin hypopigmentation
- Skin striae
- Skin ulcer
- Tachycardia
- Tremor
- Unconsciousness
- Urticaria
Less Severe
- Acneiform eruption
- Acute confusion
- Alopecia
- Apprehension
- Blistering skin
- Blurred vision
- Contact dermatitis
- Dizziness
- Dry skin
- Dyschromia
- Edema
- Euphoria
- Glycosuria
- Hirsutism
- Hypercortisolism
- Hyperesthesia
- Hyperglycemia
- Miliaria
- Nervousness
- Perioral dermatitis
- Rectal irritation
- Sensation of cold
- Sensation of warmth
- Skin irritation
- Tinnitus
- Twitching
- Vomiting
Contraindicated
Phenylephrine (Oral,Rectal)
Risk of CNS excitation. Do not use age <6 years without clinician consult.
- 1 Day – 6 Years
- 1 Risk of CNS excitation. Do not use age <6 years without clinician consult.
Severe Precaution
None
Management or Monitoring Precaution
Hydrocortisone (Top,Ophth,Rect)
Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Pediatrics are more sensitive to toxic effects.
- 1 Day – 18 Years
- Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
- 1 Day – 12 Years
- Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Pramoxine
Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Pediatrics are more sensitive to toxic effects.
- 1 Day – 18 Years
- Pediatrics are more sensitive to toxic effects.
- 1 Day – 12 Years
- Pediatrics are more sensitive to toxic effects.
Hydrocortisone (topical, Non-systemic)
- Severity Level:
2
- Additional Notes: Systemic absorption unknown; insuff human data
Phenylephrine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Pramoxine
- Severity Level:
C
- Additional Notes: Insufficient human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Phenylephrine
Oral bioavailability low; infant exposure may be minimal
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Oral bioavailability low; infant exposure may be minimal |
No Known Risk
Glycerin (as Emollient)
None
Insufficient data available; limited use may pose little risk
Per briggs, unlikely that significant amounts would be excreted in milk
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | None |
Hydrocortisone (top., Rectal)
None
Insufficient data available; limited use may pose little risk
Per briggs, unlikely that significant amounts would be excreted in milk
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Insufficient data available; limited use may pose little risk |
Pramoxine
None
Insufficient data available; limited use may pose little risk
Per briggs, unlikely that significant amounts would be excreted in milk
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Per briggs, unlikely that significant amounts would be excreted in milk |
Contraindicated
None
Precaution Exists
Phenylephrine
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Allergic dermatitis | |
| L20 | Atopic dermatitis |
| L20.0 | Besnier's prurigo |
| L20.8 | Other atopic dermatitis |
| L20.81 | Atopic neurodermatitis |
| L20.82 | Flexural eczema |
| L20.83 | Infantile (acute) (chronic) eczema |
| L20.84 | Intrinsic (allergic) eczema |
| L20.89 | Other atopic dermatitis |
| L20.9 | Atopic dermatitis, unspecified |
| L23 | Allergic contact dermatitis |
| L23.0 | Allergic contact dermatitis due to metals |
| L23.1 | Allergic contact dermatitis due to adhesives |
| L23.2 | Allergic contact dermatitis due to cosmetics |
| L23.3 | Allergic contact dermatitis due to drugs in contact with skin |
| L23.4 | Allergic contact dermatitis due to dyes |
| L23.5 | Allergic contact dermatitis due to other chemical products |
| L23.6 | Allergic contact dermatitis due to food in contact with the skin |
| L23.7 | Allergic contact dermatitis due to plants, except food |
| L23.8 | Allergic contact dermatitis due to other agents |
| L23.81 | Allergic contact dermatitis due to animal (cat) (dog) dander |
| L23.89 | Allergic contact dermatitis due to other agents |
| L23.9 | Allergic contact dermatitis, unspecified cause |
| Atopic dermatitis | |
| L20 | Atopic dermatitis |
| L20.0 | Besnier's prurigo |
| L20.8 | Other atopic dermatitis |
| L20.81 | Atopic neurodermatitis |
| L20.82 | Flexural eczema |
| L20.84 | Intrinsic (allergic) eczema |
| L20.89 | Other atopic dermatitis |
| L20.9 | Atopic dermatitis, unspecified |
| Contact dermatitis | |
| L23 | Allergic contact dermatitis |
| L23.0 | Allergic contact dermatitis due to metals |
| L23.1 | Allergic contact dermatitis due to adhesives |
| L23.2 | Allergic contact dermatitis due to cosmetics |
| L23.3 | Allergic contact dermatitis due to drugs in contact with skin |
| L23.4 | Allergic contact dermatitis due to dyes |
| L23.5 | Allergic contact dermatitis due to other chemical products |
| L23.6 | Allergic contact dermatitis due to food in contact with the skin |
| L23.7 | Allergic contact dermatitis due to plants, except food |
| L23.8 | Allergic contact dermatitis due to other agents |
| L23.81 | Allergic contact dermatitis due to animal (cat) (dog) dander |
| L23.89 | Allergic contact dermatitis due to other agents |
| L23.9 | Allergic contact dermatitis, unspecified cause |
| L24 | Irritant contact dermatitis |
| L24.0 | Irritant contact dermatitis due to detergents |
| L24.1 | Irritant contact dermatitis due to oils and greases |
| L24.2 | Irritant contact dermatitis due to solvents |
| L24.3 | Irritant contact dermatitis due to cosmetics |
| L24.4 | Irritant contact dermatitis due to drugs in contact with skin |
| L24.5 | Irritant contact dermatitis due to other chemical products |
| L24.6 | Irritant contact dermatitis due to food in contact with skin |
| L24.7 | Irritant contact dermatitis due to plants, except food |
| L24.8 | Irritant contact dermatitis due to other agents |
| L24.81 | Irritant contact dermatitis due to metals |
| L24.89 | Irritant contact dermatitis due to other agents |
| L24.9 | Irritant contact dermatitis, unspecified cause |
| L25 | Unspecified contact dermatitis |
| L25.0 | Unspecified contact dermatitis due to cosmetics |
| L25.1 | Unspecified contact dermatitis due to drugs in contact with skin |
| L25.2 | Unspecified contact dermatitis due to dyes |
| L25.3 | Unspecified contact dermatitis due to other chemical products |
| L25.4 | Unspecified contact dermatitis due to food in contact with skin |
| L25.5 | Unspecified contact dermatitis due to plants, except food |
| L25.8 | Unspecified contact dermatitis due to other agents |
| L25.9 | Unspecified contact dermatitis, unspecified cause |
| Cutaneous t-cell lymphoma | |
| C84.0 | Mycosis fungoides |
| C84.00 | Mycosis fungoides, unspecified site |
| C84.01 | Mycosis fungoides, lymph nodes of head, face, and neck |
| C84.02 | Mycosis fungoides, intrathoracic lymph nodes |
| C84.03 | Mycosis fungoides, intra-abdominal lymph nodes |
| C84.04 | Mycosis fungoides, lymph nodes of axilla and upper limb |
| C84.05 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
| C84.06 | Mycosis fungoides, intrapelvic lymph nodes |
| C84.07 | Mycosis fungoides, spleen |
| C84.08 | Mycosis fungoides, lymph nodes of multiple sites |
| C84.09 | Mycosis fungoides, extranodal and solid organ sites |
| C84.1 | Sezary disease |
| C84.10 | Sezary disease, unspecified site |
| C84.11 | Sezary disease, lymph nodes of head, face, and neck |
| C84.12 | Sezary disease, intrathoracic lymph nodes |
| C84.13 | Sezary disease, intra-abdominal lymph nodes |
| C84.14 | Sezary disease, lymph nodes of axilla and upper limb |
| C84.15 | Sezary disease, lymph nodes of inguinal region and lower limb |
| C84.16 | Sezary disease, intrapelvic lymph nodes |
| C84.17 | Sezary disease, spleen |
| C84.18 | Sezary disease, lymph nodes of multiple sites |
| C84.19 | Sezary disease, extranodal and solid organ sites |
| C84.A | Cutaneous t-cell lymphoma, unspecified |
| C84.A0 | Cutaneous t-cell lymphoma, unspecified, unspecified site |
| C84.A1 | Cutaneous t-cell lymphoma, unspecified lymph nodes of head, face, and neck |
| C84.A2 | Cutaneous t-cell lymphoma, unspecified, intrathoracic lymph nodes |
| C84.A3 | Cutaneous t-cell lymphoma, unspecified, intra-abdominal lymph nodes |
| C84.A4 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C84.A5 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C84.A6 | Cutaneous t-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C84.A7 | Cutaneous t-cell lymphoma, unspecified, spleen |
| C84.A8 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of multiple sites |
| C84.A9 | Cutaneous t-cell lymphoma, unspecified, extranodal and solid organ sites |
| C86.6 | Primary cutaneous Cd30-positive t-cell proliferations |
| Discoid lupus erythematosus | |
| H01.12 | Discoid lupus erythematosus of eyelid |
| H01.121 | Discoid lupus erythematosus of right upper eyelid |
| H01.122 | Discoid lupus erythematosus of right lower eyelid |
| H01.123 | Discoid lupus erythematosus of right eye, unspecified eyelid |
| H01.124 | Discoid lupus erythematosus of left upper eyelid |
| H01.125 | Discoid lupus erythematosus of left lower eyelid |
| H01.126 | Discoid lupus erythematosus of left eye, unspecified eyelid |
| H01.129 | Discoid lupus erythematosus of unspecified eye, unspecified eyelid |
| L93.0 | Discoid lupus erythematosus |
| Genital organ pruritus | |
| L29.2 | Pruritus vulvae |
| L29.3 | Anogenital pruritus, unspecified |
| Granuloma annulare | |
| L92.0 | Granuloma annulare |
| Hemorrhoids | |
| K64.0 | First degree hemorrhoids |
| K64.8 | Other hemorrhoids |
| K64.9 | Unspecified hemorrhoids |
| O22.4 | Hemorrhoids in pregnancy |
| O22.40 | Hemorrhoids in pregnancy, unspecified trimester |
| O22.41 | Hemorrhoids in pregnancy, first trimester |
| O22.42 | Hemorrhoids in pregnancy, second trimester |
| O22.43 | Hemorrhoids in pregnancy, third trimester |
| O87.2 | Hemorrhoids in the puerperium |
| Lichen simplex chronicus | |
| L28.0 | Lichen simplex chronicus |
| Plaque psoriasis | |
| L40.0 | Psoriasis vulgaris |
| L40.9 | Psoriasis, unspecified |
| Proctitis | |
| K62.7 | Radiation proctitis |
| K62.89 | Other specified diseases of anus and rectum |
| Pruritus ani | |
| L29.0 | Pruritus ani |
| L29.3 | Anogenital pruritus, unspecified |
| Pruritus of skin | |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| Rectal pain | |
| K62.89 | Other specified diseases of anus and rectum |
| Scalp psoriasis | |
| L40.0 | Psoriasis vulgaris |
| L40.1 | Generalized pustular psoriasis |
| L40.4 | Guttate psoriasis |
| L40.8 | Other psoriasis |
| L40.9 | Psoriasis, unspecified |
| Seborrheic dermatitis | |
| L21 | Seborrheic dermatitis |
| L21.0 | Seborrhea capitis |
| L21.1 | Seborrheic infantile dermatitis |
| L21.8 | Other seborrheic dermatitis |
| L21.9 | Seborrheic dermatitis, unspecified |
| Skin inflammation | |
| L30.8 | Other specified dermatitis |
| L30.9 | Dermatitis, unspecified |
| 0-9 | A-Z |
|---|---|
| C84.0 | Mycosis fungoides |
| C84.00 | Mycosis fungoides, unspecified site |
| C84.01 | Mycosis fungoides, lymph nodes of head, face, and neck |
| C84.02 | Mycosis fungoides, intrathoracic lymph nodes |
| C84.03 | Mycosis fungoides, intra-abdominal lymph nodes |
| C84.04 | Mycosis fungoides, lymph nodes of axilla and upper limb |
| C84.05 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
| C84.06 | Mycosis fungoides, intrapelvic lymph nodes |
| C84.07 | Mycosis fungoides, spleen |
| C84.08 | Mycosis fungoides, lymph nodes of multiple sites |
| C84.09 | Mycosis fungoides, extranodal and solid organ sites |
| C84.1 | Sezary disease |
| C84.10 | Sezary disease, unspecified site |
| C84.11 | Sezary disease, lymph nodes of head, face, and neck |
| C84.12 | Sezary disease, intrathoracic lymph nodes |
| C84.13 | Sezary disease, intra-abdominal lymph nodes |
| C84.14 | Sezary disease, lymph nodes of axilla and upper limb |
| C84.15 | Sezary disease, lymph nodes of inguinal region and lower limb |
| C84.16 | Sezary disease, intrapelvic lymph nodes |
| C84.17 | Sezary disease, spleen |
| C84.18 | Sezary disease, lymph nodes of multiple sites |
| C84.19 | Sezary disease, extranodal and solid organ sites |
| C84.A | Cutaneous t-cell lymphoma, unspecified |
| C84.A0 | Cutaneous t-cell lymphoma, unspecified, unspecified site |
| C84.A1 | Cutaneous t-cell lymphoma, unspecified lymph nodes of head, face, and neck |
| C84.A2 | Cutaneous t-cell lymphoma, unspecified, intrathoracic lymph nodes |
| C84.A3 | Cutaneous t-cell lymphoma, unspecified, intra-abdominal lymph nodes |
| C84.A4 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C84.A5 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C84.A6 | Cutaneous t-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C84.A7 | Cutaneous t-cell lymphoma, unspecified, spleen |
| C84.A8 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of multiple sites |
| C84.A9 | Cutaneous t-cell lymphoma, unspecified, extranodal and solid organ sites |
| C86.6 | Primary cutaneous Cd30-positive t-cell proliferations |
| H01.12 | Discoid lupus erythematosus of eyelid |
| H01.121 | Discoid lupus erythematosus of right upper eyelid |
| H01.122 | Discoid lupus erythematosus of right lower eyelid |
| H01.123 | Discoid lupus erythematosus of right eye, unspecified eyelid |
| H01.124 | Discoid lupus erythematosus of left upper eyelid |
| H01.125 | Discoid lupus erythematosus of left lower eyelid |
| H01.126 | Discoid lupus erythematosus of left eye, unspecified eyelid |
| H01.129 | Discoid lupus erythematosus of unspecified eye, unspecified eyelid |
| K62.7 | Radiation proctitis |
| K62.89 | Other specified diseases of anus and rectum |
| K62.89 | Other specified diseases of anus and rectum |
| K64.0 | First degree hemorrhoids |
| K64.8 | Other hemorrhoids |
| K64.9 | Unspecified hemorrhoids |
| L20 | Atopic dermatitis |
| L20 | Atopic dermatitis |
| L20.0 | Besnier's prurigo |
| L20.0 | Besnier's prurigo |
| L20.8 | Other atopic dermatitis |
| L20.8 | Other atopic dermatitis |
| L20.81 | Atopic neurodermatitis |
| L20.81 | Atopic neurodermatitis |
| L20.82 | Flexural eczema |
| L20.82 | Flexural eczema |
| L20.83 | Infantile (acute) (chronic) eczema |
| L20.84 | Intrinsic (allergic) eczema |
| L20.84 | Intrinsic (allergic) eczema |
| L20.89 | Other atopic dermatitis |
| L20.89 | Other atopic dermatitis |
| L20.9 | Atopic dermatitis, unspecified |
| L20.9 | Atopic dermatitis, unspecified |
| L21 | Seborrheic dermatitis |
| L21.0 | Seborrhea capitis |
| L21.1 | Seborrheic infantile dermatitis |
| L21.8 | Other seborrheic dermatitis |
| L21.9 | Seborrheic dermatitis, unspecified |
| L23 | Allergic contact dermatitis |
| L23 | Allergic contact dermatitis |
| L23.0 | Allergic contact dermatitis due to metals |
| L23.0 | Allergic contact dermatitis due to metals |
| L23.1 | Allergic contact dermatitis due to adhesives |
| L23.1 | Allergic contact dermatitis due to adhesives |
| L23.2 | Allergic contact dermatitis due to cosmetics |
| L23.2 | Allergic contact dermatitis due to cosmetics |
| L23.3 | Allergic contact dermatitis due to drugs in contact with skin |
| L23.3 | Allergic contact dermatitis due to drugs in contact with skin |
| L23.4 | Allergic contact dermatitis due to dyes |
| L23.4 | Allergic contact dermatitis due to dyes |
| L23.5 | Allergic contact dermatitis due to other chemical products |
| L23.5 | Allergic contact dermatitis due to other chemical products |
| L23.6 | Allergic contact dermatitis due to food in contact with the skin |
| L23.6 | Allergic contact dermatitis due to food in contact with the skin |
| L23.7 | Allergic contact dermatitis due to plants, except food |
| L23.7 | Allergic contact dermatitis due to plants, except food |
| L23.8 | Allergic contact dermatitis due to other agents |
| L23.8 | Allergic contact dermatitis due to other agents |
| L23.81 | Allergic contact dermatitis due to animal (cat) (dog) dander |
| L23.81 | Allergic contact dermatitis due to animal (cat) (dog) dander |
| L23.89 | Allergic contact dermatitis due to other agents |
| L23.89 | Allergic contact dermatitis due to other agents |
| L23.9 | Allergic contact dermatitis, unspecified cause |
| L23.9 | Allergic contact dermatitis, unspecified cause |
| L24 | Irritant contact dermatitis |
| L24.0 | Irritant contact dermatitis due to detergents |
| L24.1 | Irritant contact dermatitis due to oils and greases |
| L24.2 | Irritant contact dermatitis due to solvents |
| L24.3 | Irritant contact dermatitis due to cosmetics |
| L24.4 | Irritant contact dermatitis due to drugs in contact with skin |
| L24.5 | Irritant contact dermatitis due to other chemical products |
| L24.6 | Irritant contact dermatitis due to food in contact with skin |
| L24.7 | Irritant contact dermatitis due to plants, except food |
| L24.8 | Irritant contact dermatitis due to other agents |
| L24.81 | Irritant contact dermatitis due to metals |
| L24.89 | Irritant contact dermatitis due to other agents |
| L24.9 | Irritant contact dermatitis, unspecified cause |
| L25 | Unspecified contact dermatitis |
| L25.0 | Unspecified contact dermatitis due to cosmetics |
| L25.1 | Unspecified contact dermatitis due to drugs in contact with skin |
| L25.2 | Unspecified contact dermatitis due to dyes |
| L25.3 | Unspecified contact dermatitis due to other chemical products |
| L25.4 | Unspecified contact dermatitis due to food in contact with skin |
| L25.5 | Unspecified contact dermatitis due to plants, except food |
| L25.8 | Unspecified contact dermatitis due to other agents |
| L25.9 | Unspecified contact dermatitis, unspecified cause |
| L28.0 | Lichen simplex chronicus |
| L29.0 | Pruritus ani |
| L29.2 | Pruritus vulvae |
| L29.3 | Anogenital pruritus, unspecified |
| L29.3 | Anogenital pruritus, unspecified |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| L30.8 | Other specified dermatitis |
| L30.9 | Dermatitis, unspecified |
| L40.0 | Psoriasis vulgaris |
| L40.0 | Psoriasis vulgaris |
| L40.1 | Generalized pustular psoriasis |
| L40.4 | Guttate psoriasis |
| L40.8 | Other psoriasis |
| L40.9 | Psoriasis, unspecified |
| L40.9 | Psoriasis, unspecified |
| L92.0 | Granuloma annulare |
| L93.0 | Discoid lupus erythematosus |
| O22.4 | Hemorrhoids in pregnancy |
| O22.40 | Hemorrhoids in pregnancy, unspecified trimester |
| O22.41 | Hemorrhoids in pregnancy, first trimester |
| O22.42 | Hemorrhoids in pregnancy, second trimester |
| O22.43 | Hemorrhoids in pregnancy, third trimester |
| O87.2 | Hemorrhoids in the puerperium |
Formulary Reference Tool